Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis

Autor:	Marius Horger, Jörg Henes, Sebastian-Jonas Saur
Rok vydání:	2021
Předmět:	medicine.medical_specialty business.industry Takayasu's arteritis Takayasu arteritis Antagonist medicine.disease Dermatology Letter to the Editor (Case report) Rheumatology Refractory Ustekinumab Interleukin 23 Interleukin 12 Medicine AcademicSubjects/MED00010 business medicine.drug
Zdroj:	Rheumatology Advances in Practice
ISSN:	2514-1775
DOI:	10.1093/rap/rkaa082
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d01a3d81ff58952f1d5c59c00e0f69ae https://doi.org/10.1093/rap/rkaa082 Zobrazit plný text záznamu